MSD is Charity Supporting Partner at the Swiss City Marathon Lucerne

Lucerne, August 28, 2018. MSD Merck Sharp & Dohme AG will be supporting the Swiss City Marathon Lucerne as Charity Supporting Partner as of 2018. The research-based biopharmaceutical company located in Lucerne has been supporting this regionally and nationally important marathon since 2010.

Being goal-oriented, ambitious and persevering are decisive criteria in a sporting and entrepreneurial context. Even better if competence and awareness of a healthy lifestyle are promoted at the same time. With over 700 employees at four locations in the canton of Lucerne, this commitment of MSD is part of its corporate responsibility towards its employees, the location and the people of Lucerne. Social commitment is an additional motivation. Running for a good cause has been part of MSD's commitment to the Swiss City Marathon Lucerne since the beginning.

MSD and UNICEF: Going the Extra Mile

As of 2018, MSD will support UNICEF Switzerland, the Charity Partner at the Swiss City Marathon Lucerne as the Charity Supporting Partner. In 2018, all runners who complete their 10, 21 and 42-kilometre distances will be invited to run an Extra Mile for a good cause. At least 2,000 runners must run the Extra Mile to achieve CHF 20,000, the amount of donation formulated by MSD.

In 2018, the donation will support the UNICEF project "Fighting malnutrition in Southern Sudan". Since 2013, the population of Southern Sudan has been suffering from ongoing civil wars resulting among others in malnutrition. Infants are particularly affected. With the help of UNICEF, malnourished children receive special therapeutic milk and special food so they can regain their strength.

Everyone can help: as a marathon or half-marathon charity runner or as a 10-kilometer leisure runner. Further possibilities are also listed on the website of Swiss City Marathon Lucerne. All donations go to UNICEF Switzerland for the benefit of children in need in Southern Sudan.

Further information:

About MSD

MSD is a leading global biopharmaceutical company which has been engaged in life science research for more than a century, developing drugs and vaccines for the most challenging diseases worldwide. MSD is a registered trademark of Merck & Co., Inc., Kenilworth, New Jersey, USA. With our prescription drugs, vaccines, biological therapies, and veterinary products, we offer innovative health solutions in over 140 countries. With wide-ranging programs and partnerships, we are also committed to achieving improved access to healthcare. Today MSD is still at the forefront of research for the prevention and treatment of diseases which threaten people and society around the world, including cancer, cardiovascular diseases, new animal diseases, Alzheimer’s, and infectious diseases, including HIV and Ebola. For more information visit and follow us on Twitter.

MSD Human Medicine Switzerland

Switzerland is a key location for the company, which has 600 employees working there in national and international functions. The Human Medicine division in Switzerland is responsible for the distribution of prescription drugs and biopharmaceuticals in the areas of oncology, diabetes, cardiovascular diseases, infectious diseases (including anti-fungal, antibiotic resistance, HIV/Aids, and hepatitis C), immunology, women’s health as well as vaccines for children, young people, and adults.

MSD is active in clinical research in Switzerland, where the company provides medicines for clinical trials worldwide. Additionally, MSD is committed to raising health literacy and promoting the healthcare economy on a local level. The firm is also active in Lucerne, where the MSD headquarters are located. In 2018 the company received certification as a “Top Employer” in Switzerland for the sixth year in succession, as well as the “Top Employer Europe” award for the third time.

More information is available at:

Press contact:
Liliane Elspass, Lead Communications
MSD Merck Sharp & Dohme AG
Tel. +41 58 618 34 24 / Mobile 079 235 58 90

© 2018 MSD Merck Sharp & Dohme AG, Werftestrasse 4, 6005 Luzern. All rights reserved.

CORP-1268084-0000, August 2018